Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has released a final director’s interest notice indicating that Jennifer Chow ceased her director role on May 24, 2024. The notice details Chow’s holdings, which include 1,811,609 ordinary shares and a substantial number of unlisted options and performance rights. The company has disclosed these changes in accordance with ASX listing rules and the Corporations Act.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
